Wednesday, February 19, 2003

"Reporting of Serious Adverse Events"
Speaker: Wendy Fanaroff-Ravick

"Bio-Defense and Emerging Infections"
Speaker:  David Franz D.V.M., Ph.D.

Thursday, February 20, 2003

"Overview-Directions for the CASG"
Speaker: Richard J. Whitley, M.D.

"Global Clinical Trial Issues: Regulatory/Ethics Mini Symposium Ethics in Clinical Trials"
Speaker: David Wendler

"Immunocompromised Host"
Speaker: Paul Griffiths, M.D.

"HSV Infections of the CNS in Adults"
Speaker: Kenneth Tyler, M.D.

"Enterovirus (#106) Trial"
Speakers: Mark Abzug, M.D. & David Kimberlin, M.D.

"BK Virus (#209)"
Speaker: Ajit Limaye, M.D.

*To get information on West Nile, visit the CDC website

Friday, February 21, 2003

"Neonatal Herpesviruses: New Analyses"
Speaker: Richard J. Whitley, M.D.

"HSV CNS (103) and HSV SEM (104)"
Speaker: David Kimberlin, M.D.

"CMV Follow-up (108) and Valgan (109)"
Speaker: David Kimberlin, M.D.

"HSE (204)"
Speaker: John Gnann, M.D.


Breakout Sessions

"Adult Transplantation Subcommittee"
Speaker: Paul Griffiths, M.D.

"Pediatric Enterovirus"
Speaker: Mark Abzug, M.D.

"Pediatric Herpesviruses"
Speaker: David Kimberlin, M.D.

"West Nile Virus"
Speaker: Amy Agrawal, M.D.